Taiwan FDA registration c4bcb7f1a412a0e13230b6be655e9eb9
"Simogine" RESI Blood Bank Centrifuge for In Vitro Diagnostics (Unsterilized)
TW: "詩莫吉內" 睿思體外診斷用血庫離心機 (未滅菌)
Taiwan·Risk Class 1·THERMOGENESIS CORPORATION·Registered Mar 12, 2012 – Mar 12, 2017CancelledRegistration details
- Analysis ID
- c4bcb7f1a412a0e13230b6be655e9eb9
- Customs Code
- DHA04401145802
Company information
- Manufacturer
- THERMOGENESIS CORPORATION
- Manufacturer Country
- United States
- Authorized Representative
- Polytechnic Technology Engineering Consultants Limited
Product details
- Intended Use
- Limited to the first level identification range of blood bank centrifuge (B.9275) for in vitro diagnostic of medical equipment management methods.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.9275 Blood bank centrifuge for in vitro diagnostics
- Import Information
- QMS/QSD;; 輸入
Dates and status
- Registration Date
- Mar 12, 2012
- Expiry Date
- Mar 12, 2017
- Cancellation Date
- Nov 15, 2019
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for "Simogine" RESI Blood Bank Centrifuge for In Vitro Diagnostics (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number c4bcb7f1a412a0e13230b6be655e9eb9 and manufactured by THERMOGENESIS CORPORATION. The authorized representative in Taiwan is Polytechnic Technology Engineering Consultants Limited.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices